Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando de Mora

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 9, 2019
Biosimilars: A Value PropositionFernando de Mora
British Journal of Clinical Pharmacology|April 14, 2015
Biosimilar: what it is notFernando de Mora
Drug Discovery Today|March 6, 2024
Is calcitonin gene-related peptide (CGRP) the missing link in food histamine-induced migraine? A review of functional gut-to-trigeminovascular system connectionsFernando de Mora, Karl Messlinger
Drug Discovery Today|February 24, 2023
Randomized controlled trials do not always fit the purpose: A science-based response to Venetis and Mol's editorial on biosimilars of follitropin alfaFernando de Mora, Colin M Howles
Drug Discovery Today|May 1, 2022
Overlapping biosimilar and originator follitropin alfa preparations: How much closer can they get?Fernando de Mora, Colin M Howles
Archivos De Bronconeumologia|July 28, 2009
[Again an asthma model... but a useful one]Rosa Torres, César Picado, Fernando de Mora
Drug Discovery Today|May 22, 2021
Extrapolation: Experience gained from original biologicsLuisa-Fernanda Rojas-Chavarro, Fernando de Mora
Molecular Immunology|April 29, 2014
The PGE2-EP2-mast cell axis: an antiasthma mechanismRosa Torres, César Picado, Fernando de Mora
Reproductive Biomedicine Online|May 3, 2017
Biosimilars to recombinant human FSH medicines: comparable efficacy and safety to the original biologicFernando de Mora, Bart C J M Fauser
Human Reproduction (Oxford, England)|July 27, 2025
Follitropin alfa biosimilars: unfounded doubts on the road to reproductive careFernando de Mora, Colin M Howles, Geoffrey Trew
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 9, 2019
Biosimilars: A Value PropositionFernando de Mora
British Journal of Clinical Pharmacology|April 14, 2015
Biosimilar: what it is notFernando de Mora
Drug Discovery Today|March 6, 2024
Is calcitonin gene-related peptide (CGRP) the missing link in food histamine-induced migraine? A review of functional gut-to-trigeminovascular system connectionsFernando de Mora, Karl Messlinger
Drug Discovery Today|February 24, 2023
Randomized controlled trials do not always fit the purpose: A science-based response to Venetis and Mol's editorial on biosimilars of follitropin alfaFernando de Mora, Colin M Howles
Drug Discovery Today|May 1, 2022
Overlapping biosimilar and originator follitropin alfa preparations: How much closer can they get?Fernando de Mora, Colin M Howles
Archivos De Bronconeumologia|July 28, 2009
[Again an asthma model... but a useful one]Rosa Torres, César Picado, Fernando de Mora
Drug Discovery Today|May 22, 2021
Extrapolation: Experience gained from original biologicsLuisa-Fernanda Rojas-Chavarro, Fernando de Mora
Molecular Immunology|April 29, 2014
The PGE2-EP2-mast cell axis: an antiasthma mechanismRosa Torres, César Picado, Fernando de Mora
Reproductive Biomedicine Online|May 3, 2017
Biosimilars to recombinant human FSH medicines: comparable efficacy and safety to the original biologicFernando de Mora, Bart C J M Fauser
Human Reproduction (Oxford, England)|July 27, 2025
Follitropin alfa biosimilars: unfounded doubts on the road to reproductive careFernando de Mora, Colin M Howles, Geoffrey Trew
Pageof 3